S3 Guideline "Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment" - Short Version.


Journal

European addiction research
ISSN: 1421-9891
Titre abrégé: Eur Addict Res
Pays: Switzerland
ID NLM: 9502920

Informations de publication

Date de publication:
2022
Historique:
received: 20 11 2021
accepted: 22 04 2022
pubmed: 28 6 2022
medline: 15 9 2022
entrez: 27 6 2022
Statut: ppublish

Résumé

In addition to the prevention of tobacco consumption, the establishment and assurance of high-quality treatment for harmful use and dependence on tobacco products remains an important health-related task in Germany. Regular updating of the Association of the Scientific Medical Societies (AWMF) S3 guideline "Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment" (Tobacco Guideline) offers a sustainable and reputable source of knowledge on smoking cessation. Under the auspices of the German Society for Psychiatry, Psychotherapy, Psychosomatics, and Neurology (DGPPN) and the German Society for Addiction Research and Addiction Therapy (DG-Sucht), the Tobacco Guideline was revised in 2019-2020 by 63 experts, who were involved in the development process of the text, in 11 working groups. Undue influence of conflicts of interest on the guideline could be minimized through careful conflict of interest management. Delegates from 50 professional societies discussed the 80 guideline recommendations and voted online. In addition to recommendations for screening and diagnostics, the Tobacco Guideline takes a positive stance towards the use of low-threshold counseling and support services. If, due to the severity of the tobacco-related disorder, brief counseling, telephone counseling, or internet- or smartphone-based methods are not sufficiently effective, individual or group behavioral therapy, possibly in combination with medication, is indicated. If nicotine replacement therapy is not effective, varenicline or bupropion should be offered. Alternative strategies with a lower level of recommendation are hypnotherapy, mindfulness-based treatments, or medication with cytisine. In adolescents and pregnant women, the use of medication should be limited to well-specified exceptions and nicotine replacement. The mean agreement with the recommendations reached a value of 98%. A general overview of the treatment recommendations of the Tobacco Guideline is provided by three clinical algorithms.

Identifiants

pubmed: 35760048
pii: 000525265
doi: 10.1159/000525265
doi:

Substances chimiques

Varenicline W6HS99O8ZO

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

382-400

Informations de copyright

© 2022 S. Karger AG, Basel.

Auteurs

Anil Batra (A)

Sektion Suchtmedizin des Universitätsklinikums Tübingen, Tübingen, Germany.

Falk Kiefer (F)

Klinik für Abhängiges Verhalten und Suchtmedizin, Zentralinstitut für Seelische Gesundheit, Mannheim/Lehrstuhl für Suchtforschung, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany.

Stefan Andreas (S)

Fachklinik für Lungenerkrankungen Philippsstiftung e.V, Immenhausen, Universitätsmedizin Göttingen, Deutsches Zentrum für Lungenforschung, Göttingen, Germany.

Helmut Gohlke (H)

Deutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung e. V., Düsseldorf, Germany.

Marianne Klein (M)

Zentrum für Psychiatrie, Klinikum Schloss Winnenden, Winnenden, Germany.

Daniel Kotz (D)

Institut für Allgemeinmedizin (ifam), Schwerpunkt Suchtforschung und klinische Epidemiologie, Centre for Health and Society (chs), Medizinische Fakultät der Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.

Ute Mons (U)

Stabsstelle Krebsprävention, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Medizinische Fakultät und Universitätsklinikum Köln, Universität zu Köln, Köln, Germany.

Stephan Mühlig (S)

Klinische Psychologie und Psychotherapie TU Chemnitz, Chemnitz, Germany.

Martina Pötschke-Langer (M)

Deutsche Hauptstelle für Suchtfragen, Hamm, Germany.

Ulrich W Preuss (UW)

Vitos Klinik für Psychiatrie und Psychotherapie Herborn, Herborn, Germany.

Tobias Rüther (T)

Spezialambulanz für Tabakabhängigkeit, LMU Klinikum München, Klinik für Psychiatrie und Psychotherapie, Munich, Germany.

Christa Rustler (C)

Frauen aktiv contra Tabak e.V., Hannover, Germany.

Rainer Thomasius (R)

Deutsches Zentrum für Suchtfragen des Kindes- und Jugendalters, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.

Sabina Ulbricht (S)

Universitätsmedizin Greifswald, Institut für Community Medicine, Abteilung Präventionsforschung und Sozialmedizin, Greifswald, Germany.

Kay Uwe Petersen (KU)

Sektion Suchtmedizin des Universitätsklinikums Tübingen, Tübingen, Germany, Kay.Petersen@med.uni-tuebingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH